⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of PT Pyridam Farma Tbk and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
PT Pyridam Farma Tbk
↗Jakarta, Indonesia
PT Pyridam Farma Tbk (PYFA) is a prominent Indonesian pharmaceutical company established in 1976 and listed on the Indonesia Stock Exchange. The company is engaged in the production, development, and distribution of a wide range of pharmaceutical products, including antibiotics, vitamins, health supplements, and traditional medicines, as well as medical devices and laboratory equipment.
In recent years, the company has pursued an aggressive expansion strategy, including the acquisition of PT Holi Pharma and PT Ethica Industri Farmasi to strengthen its manufacturing capabilities and product portfolio. PYFA operates across multiple segments, including pharmaceutical products, esthetics, toll manufacturing, and medical equipment, with a distribution network covering all 34 provinces in Indonesia.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Pharmaceuticals & Medical Devices
SIZE & FINANCIALS
Employees:501-1000
Founded:1976
Ownership:public
Status:operating
STOCK
Exchange:IDX
Ticker:PYFA
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:PT Holi Pharma, PT Ethica Industri Farmasi, PYFA Australia Pty Ltd
Key Partnerships:PharmaNutra (Distribution of SiderAL products), Genewel (Strategic partnership for wound care and drug delivery)
COMPETITION
Position:Challenger
LEADERSHIP
Key Executives:
Lee Yan Gwan - President Director
Yenfrino Gunadi - Director / CFO
LINKS
Website:pyfa.co.id
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PT Pyridam Farma Tbk. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.